Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06418711
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-05-08
Brief Title:
ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101 Clofazimine Inhalation Suspension
Sponsor:
Organization:
Mannkind Corporation